Back to top
more

Owens & Minor (OMI)

(Delayed Data from NYSE)

$16.13 USD

16.13
419,865

-0.24 (-1.47%)

Updated Aug 26, 2024 04:00 PM ET

After-Market: $16.12 -0.01 (-0.06%) 6:04 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

What's in Store for Cardinal Health (CAH) in Q4 Earnings?

by Zacks Equity Research

Cardinal Health's (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.

Should You Buy, Sell or Hold McKesson (MCK) Before Q1 Earnings?

by Zacks Equity Research

McKesson's (MCK) first-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.

Maharathi Basu headshot

5 Stocks Loved by Brokers Worth Watching Currently

by Maharathi Basu

Investors would do well to monitor stocks like ADTRAN (ADTN), Bread Financial (BFH), Owens & Minor (OMI), Bally's Corporation (BALY) and AMC Networks (AMCX) for high returns.

Baxter (BAX) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Baxter's (BAX) second-quarter results are likely to benefit from positive pricing impact and new product launches. However, supply-chain issues are likely to have raised expenses in the quarter.

Owens & Minor (OMI) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Owens & Minor (OMI) delivered earnings and revenue surprises of 9.09% and 0.79%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

BellRing Brands (BRBR) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

BellRing Brands (BRBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can RadNet's (RDNT) Service Fee Revenues Help Lift Q2 Earnings?

by Zacks Equity Research

RadNet's (RDNT) Imaging Center segment is likely to have gained from the increased reimbursement from commercial and capitated payors and strong procedure volumes in the second quarter of 2024.

Will Owens & Minor (OMI) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Owens & Minor (OMI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Owens & Minor (OMI) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Owens & Minor (OMI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wall Street Analysts Believe Owens & Minor (OMI) Could Rally 29.48%: Here's is How to Trade

by Zacks Equity Research

The consensus price target hints at a 29.5% upside potential for Owens & Minor (OMI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Owens & Minor (OMI) Stock Jumps 7.6%: Will It Continue to Soar?

by Zacks Equity Research

Owens & Minor (OMI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

biote Corp. (BTMD) Surges 10.4%: Is This an Indication of Further Gains?

by Zacks Equity Research

biote Corp. (BTMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Should Value Investors Buy Owens & Minor (OMI) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Omnicell (OMCL) Q1 Earnings Top Estimates, Revenues Down Y/Y

by Zacks Equity Research

Omnicell (OMCL) outpaces expectations in the first quarter of 2024 in a challenging customer environment.

Owens & Minor (OMI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

The headline numbers for Owens & Minor (OMI) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

BellRing Brands Inc. (BRBR) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Owens & Minor, Inc. (OMI) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Owens & Minor (OMI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Are Investors Undervaluing Owens & Minor (OMI) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Owens & Minor (OMI) Q4 Earnings Surpass Estimates

by Zacks Equity Research

Owens & Minor (OMI) delivered earnings and revenue surprises of 1.47% and 0.26%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Prestige Consumer Healthcare (PBH) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of 1.92% and 0.89%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Is Owens & Minor (OMI) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Owens & Minor (OMI) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

Owens & Minor (OMI) delivered earnings and revenue surprises of 22.22% and 1.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Abbott (ABT) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Abbott (ABT) delivered earnings and revenue surprises of 3.64% and 3.60%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Is the Options Market Predicting a Spike in Owens & Minor (OMI) Stock?

by Zacks Equity Research

Investors need to pay close attention to Owens & Minor (OMI) stock based on the movements in the options market lately.

Are Options Traders Betting on a Big Move in Owens & Minor (OMI) Stock?

by Zacks Equity Research

Investors need to pay close attention to Owens & Minor (OMI) stock based on the movements in the options market lately.